In utero exposure to vigabatrin: No indication of visual field loss

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Epilepsia

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1528-1167.2008.01700.xPMID 18616557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vigabatrin and Epilepsy: Lessons Learned

  2007cited by this paper
• Incidence of Vigabatrin Attributed Visual Toxicity Is Reduced in Infants Taking the Drug for Less Than versus More Than One Year Duration

  2007influential reference
• Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.

  2006cited by this paper
• Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin: ocular safety pilot results.

  2006cited by this paper
• Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero.

  2005influential reference
• Placental transfer of vigabatrin (gamma-vinyl GABA) and its effect on concentration of amino acids in the embryo of TO mice.

  2001cited by this paper
• Visual Field Defects with Vigabatrin

  2001cited by this paper
• Characteristics of a Unique Visual Field Defect Attributed to Vigabatrin

  1999cited by this paper
• Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.

  1998cited by this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cited by this paper
• Passage of S(+) and R(-) gamma-vinyl-GABA across the human isolated perfused placenta.

  1992cited by this paper

• A Novel Strategy for Attenuating Opioid Withdrawal in Neonates

  2016cites this paper
• Epilepsy and antiepileptic medications

  2015cites this paper
• Foetal safety of old and new antiepileptic drugs

  2015cites this paper
• Some long-term outcomes of visual dysfunction arising from vigabatrin ocular toxicity

  2014cites this paper
• Spezielle Arzneimitteltherapie in der Schwangerschaft

  2013cites this paper
• Antiepileptic drugs and pregnancy outcomes

  2012cites this paper
• Vigabatrin monotherapy for infantile spasms

  2012cites this paper
• Second-generation antiepileptic drugs and pregnancy: a guide for clinicians

  2012cites this paper
• Epilepsy: Vigabatrin treatment and visual field loss

  2011cites this paper
• Epilepsy and Anticonvulsant Therapy During Pregnancy

  2011cites this paper
• Vigabatrin (VGB) administered during late gestation lowers maternal folate concentration and causes pregnancy loss, fetal growth restriction and skeletal hypoplasia in the mouse.

  2010cites this paper
• Teratogenic effects of antiepileptic drugs

  2010cites this paper
• Evaluating Risks for Vigabatrin Treatment

  2009cites this paper